Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients.

Akira Mitsuhashi Yuji Habu Tatsuya Kobayashi Yoshimasa Kawarai Hiroshi Ishikawa Hirokazu Usui Makio Shozu

Published in: Journal of gynecologic oncology (2020)

MPA plus metformin is efficacious in terms of RFS and post treatment conception. Moreover, metformin may be more efficacious for patients with BMI ≥25 kg/m².

Keyphrases

endometrial cancer
combination therapy
young adults
robot assisted
weight loss